Chi Hoon Maeng

Priorities of a “good death” according to cancer patients, their family caregivers, physicians, and the general population: a nationwide survey

Young Ho Yun, Kyoung‐Nam Kim, Jin-Ah Sim et al. · Supportive Care in Cancer · 2018 · 61 citations

Medicine, Oncology, End-of-life Care +10

The immunohistochemical overexpression of ribonucleotide reductase regulatory subunit M1 (RRM1) protein is a predictor of shorter survival to gemcitabine-based chemotherapy in advanced non-small cell lung cancer (NSCLC)

Jae Jin Lee, Chi Hoon Maeng, Seon Kyung Baek et al. · Lung Cancer · 2010 · 59 citations

Medicine, Molecular Biology, Oncology +11

The impact of baseline and interim PET/CT parameters on clinical outcome in patients with diffuse large B cell lymphoma

Silvia Park, Seung Hwan Moon, Lee Chun Park et al. · American Journal of Hematology · 2012 · 49 citations · Full text

Medicine, Oncology, Radiology +16

A Phase III Study to Compare the Efficacy and Safety of Paclitaxel Versus Irinotecan in Patients with Metastatic or Recurrent Gastric Cancer Who Failed in First-line Therapy (KCSG ST10-01)

Keun‐Wook Lee, Chi Hoon Maeng, Tae‐You Kim et al. · The Oncologist · 2018 · 45 citations · Full text

Medicine, Oncology, Pharmacology +12

Attitudes of the General Public, Cancer Patients, Family Caregivers, and Physicians Toward Advance Care Planning: A Nationwide Survey Before the Enforcement of the Life-Sustaining Treatment Decision-Making Act

Hye Yoon Park, Young Ae Kim, Jin-Ah Sim et al. · Journal of Pain and Symptom Management · 2018 · 41 citations

Medicine, Health Policy, End-of-life Care +12